Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2679)	1/24/2001 11:25:12 PM
From: Ian@SI	Respond to of 52153

Bernard, I haven't looked into the Biotech holders specifically. Usually these "holders" have been a very expensive way to buy a set of companies that one could acquire on one's own. Further with a little insight and intelligence, the basket can be outperformed with less risk and with less cost. If someone doesn't have access to medical insight; or has limited funds to invest in the sector, then the holders or a low MER biotech fund would probably be a worthwhile approach. Ian..